Back to Search
Start Over
Advances in Medical Treatment of Primary Aldosteronism.
- Source :
-
Chinese Medical Sciences Journal . Mar2023, Vol. 38 Issue 1, p49-56. 8p. - Publication Year :
- 2023
-
Abstract
- Primary aldosteronism (PA) is the most common form of secondary hypertension, with its main manifestations including hypertension and hypokalemia. Early identification of PA is extremely important as PA patients can easily develop cardiovascular complications such as atrial fibrillation, stroke, and myocardial infarction. The past decade has witnessed the rapid advances in the genetics of PA, which has shed new light on PA treatment. While surgery is the first choice for unilateral diseases, bilateral lesions can be treated with mineralocorticoid receptor antagonists (MRAs). The next-generation non-steroidal MRAs are under investigations. New medications including calcium channel blockers, macrophage antibiotics, and aldosterone synthase inhibitors have provided a new perspective for the medical treatment of PA. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 10019294
- Volume :
- 38
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Chinese Medical Sciences Journal
- Publication Type :
- Academic Journal
- Accession number :
- 163164747
- Full Text :
- https://doi.org/10.24920/004137